Skip to main content
Search hero banner

Search results

Showing 161 - 180 of 1059 results

Plans to safely manage medical and research waste

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

Exchange of expertise

A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.

Management of nuclear reactor fuel

Management of nuclear reactor fuel

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.

Scientists

Australian Critical Minerals Research & Development Hub

The Australian Critical Minerals Research and Development Hub (the Hub) unites the expertise of top Federal science agencies: ANSTO, Geoscience Australia, and CSIRO with the aim of addressing technical challenges and drive collaborative research across the critical minerals value chain.

paperwork

United Uranium Scholarship - Guidelines

This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.

The world’s best radon detector just got smaller

The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.

High Performance Macromolecular Crystallography Beamline (MX3)

High Performance Macromolecular Crystallography Beamline (MX3)

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Pagination